CRL
CRL
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
4
$1.26M
Insider Sales
21
$54.79M
Total Volume
$56.05M
25 transactions
Net Activity
$53.53M
Net selling
Sentiment Rating
Strong AccumulationCEO Conviction Index
High Conviction Accumulation
Key Drivers
- •Heavy distribution: sales represent 98% of total transaction value.
- •Cluster buying: 4 unique insiders purchased shares, showing strong alignment.
- •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
- •CFO buying activity detected. Statistical studies show CFO purchases have high predictive power due to their direct visibility into balance sheet details.
- •High accumulation: total purchase value exceeds $1M.
- •Significant liquidation: total sale value exceeds $10M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Foster James C
Dir
$44.26M total
Parisotto Shannon M
CEVP, Disc, Safety Assessment
$4.01M total
Girshick Birgit
CEO
$2.07M total
Knell Michael Gunnar
SVP, Finance, CAO
$1.73M total
Wallman Richard F
Dir
$1.65M total
Quick Actions
CRL has an insider buy conviction of 2%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at CRL (CRL) engaged in a total of 25 transactions reported via SEC Form 4 filings. Among these, 4 were open-market purchases and 21 were sales. The total volume of insider trading reached $56.05M.
The net insider activity for CRL shows a net selling bias of $53.53M. This activity represents a 2% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Foster James C (Dir), who traded 75.0K shares valued at $16.88M on Jun 29, 2026.
Charles River Laboratories (CRL) Stock Looks Fairly Valued Despite Its 106% Run
(CRL) Movement as an Input in Quant Signal Sets
Charles River (CRL) Stock Could Be 27% Overvalued As Preclinical FDA Collaboration Starts
Summit Therapeutics Provides Update Regarding Ivonescimab Biologics License Application
Charles River Laboratories International (NYSE:CRL) Stock Forecast & Analyst Predictions
Why Charles River Laboratories (CRL) Stock Is Up Today
FAQs About CRL Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for CRL.